Home Link (JNJ Logo) Change Country Johnson & Johnson Announces Plans to Separate Consumer Health Business Learn More Our Board Vote Submit a Question Join Webcast Join Annual Meeting Webcast 2021 Annual Meeting of Shareholders April 22, 2021, 10:00 AM Eastern Time Notice of Annual Meeting Y ou are invited to attend the Annual Meeting of Shareholders of Johnson & Johnson. Due to ongoing public health concerns regarding the COVID-19 pandemic and for the health and well-being of our shareholders, directors, management and associates, the 2021 Annual Meeting will be held online in a virtual format. Shareholders as of the record date may attend, vote and submit questions virtually at our Annual Meeting by logging in at www.proxyvote.com/JNJ. To log in, shareholders (or their authorized representatives) will need the 16-digit control number provided on your notice, on your proxy card or in the voting instructions that accompanied your proxy materials. On the day of the meeting shareholders should log into the virtual meeting url: www.virtualshareholdermeeting.com/JNJ2021. As of this date, a state of emergency is in effect in the State of New Jersey relating to the COVID-19 pandemic. Johnson & Johnson is permitted to hold a virtual meeting of shareholders under New Jersey law so long as a state of emergency remains in effect. In the event that the state of emergency is lifted prior to the date fixed for the 2021 Annual Meeting, and it is not, therefore, then legally permissible to hold a completely virtual annual meeting under New Jersey law, we will announce alternative arrangements for the 2021 Annual Meeting as promptly as practicable. Any such change will be announced via press release and website posting, as well as the filing of additional Proxy materials with the Securities and Exchange Commission. Join Annual Meeting Webcast 2021 Annual Shareholder Meeting Materials 2020 Annual Report Download 2021 Proxy Statement Download Meeting Agenda Download Rules of Order & FAQs Download Corporate Reports and Resources Health for Humanity Report Diversity, Equity & Inclusion Impact Review Janssen U.S. Transparency Report Our COVID-19 Response Efforts Hear From Our Lead Director Read Anne M. Mulcahy's Letter Hear From Our Chairman and CEO Read Alex Gorsky's Letter Our Director Nominees alt Alex Gorsky headshot Alex Gorsky Chairman, Board of Directors and Chief Executive Officer Mary C. Beckerle, Ph.D. Chief Executive Officer, Huntsman Cancer Institute at the University of Utah; Distinguished Professor of Biology and Oncological Sciences, University of Utah D. Scott Davis Former Chairman and Chief Executive Officer, United Parcel Service, Inc. Ian E. L. Davis Non-Executive Chairman, Rolls-Royce Holdings plc; Former Chairman and Worldwide Managing Director, McKinsey & Company Jennifer A. Doudna, Ph.D. Professor of Chemistry; Professor of Biochemistry & Molecular Biology; Li Ka Shing Chancellor's Professorship in Biomedical and Health, University of California, Berkeley Marillyn A. Hewson Former Chairman, President and Chief Executive Officer, Lockheed Martin Corporation Hubert Joly Former Chairman and Chief Executive Officer, Best Buy Co., Inc. Mark B. McClellan, M.D., Ph.D. Director, Duke-Robert J. Margolis, MD, Center for Health Policy; Margolis Professor of Business Medicine and Policy, Duke University Anne M. Mulcahy Former Chairman and Chief Executive Officer, Xerox Corporation Charles Prince Former Chairman and Chief Executive Officer, Citigroup Inc. A. Eugene Washington, M.D., M.Sc. Duke University’s Chancellor for Health Affairs; President and Chief Executive Officer, Duke University Health System Mark A. Weinberger Former Global Chairman and Chief Executive Officer, EY (Ernst & Young) Nadja Y. West, M.D. Retired United States Army Lieutenant General and Former United States Army Surgeon General Ronald A. Williams Former Chairman and Chief Executive Officer, Aetna Inc. Director Highlights expand expand Items of Business — Voting Overview and Vote Recommendations of Board expand Your Voice Counts We encourage you to vote and submit a question in advance of the Annual Meeting. Visit the Site QUICK LINKS Latest News Careers Privacy Policy About J&J Media Center Cookie Policy Legal Notice Products Investors Employees Procurement Our Societal Impact Contact Us Credo Integrity Line MORE FROM JOHNSON & JOHNSON Janssen Janssen Pharmaceutical Companies of Johnson & Johnson Johnson & Johnson Medical Devices Companies Johnson & Johnson Medical Devices Companies Reimagining the Way Healthcare Is Delivered Johnson & Johnson Consumer Health Johnson & Johnson Consumer Health Meeting the Personal Care and Wellness Needs of Consumers Worldwide Our Consumer Safety and Care Commitment Our Consumer Safety and Care Commitment Your Safety Is Our Priority Johnson & Johnson Innovation Johnson & Johnson Innovation Advancing New Healthcare Solutions Through Collaboration Johnson & Johnson Our Story Johnson & Johnson Our Story Learn About the Company's Rich Heritage at Our Digital Museum FOLLOW US Facebook facebook Instagram instagram LinkedIn linkedin Twitter twitter YouTube youtube This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information. Do Not Sell My Personal Information All contents © Copyright Johnson & Johnson Services, Inc.1997-2021. All Rights Reserved. This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies. Accept